2invest AG (ETR:2INV)
Germany · Delayed Price · Currency is EUR 11.40
0.00 (0.00%)
At close: Jan 6, 2026
2invest AG Revenue
2invest AG had revenue of -2.31M EUR in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to -1.64M.
Revenue (ttm)
-1.64M
Revenue Growth
n/a
P/S Ratio
-26.56
Revenue / Employee
-328.60K
Employees
6
Market Cap
43.64M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 3.01M | 1.20M | 66.23% |
| Dec 31, 2021 | 1.81M | 1.74M | 2,526.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Biotest GmbH & Co. KGaA | 648.90M |
| Novogenia AG | 54.30M |
| Paion AG | 14.81M |
| MagForce AG | 1.08M |
| Biomark Diagnostics | 37.15K |
| co.don AG | 22.00K |
| bioXXmed AG | 16.73K |
| 2invest AG | -1.64M |